Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. (Q53920352)

22 May 2018

title

Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. (English)

1 reference

22 May 2018

0 references

E Korn-Merker

1

1 reference

22 May 2018

P Borusiak

series ordinal

2

1 reference

22 May 2018

H E Boenigk

series ordinal

3

1 reference

22 May 2018

publication date

1 January 2000

1 reference

22 May 2018

published in

Epilepsy Research

1 reference

22 May 2018

volume

38

1 reference

22 May 2018

issue

1

1 reference

22 May 2018

page(s)

27-32

1 reference

22 May 2018

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

1 reference

7 January 2021

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Efficacy of gabapentin therapy in children with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Behavioral side effects of gabapentin in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Double-blind study of Gabapentin in the treatment of partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Discontinuation of clonazepam after long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

A summary of mechanistic hypotheses of gabapentin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

Gabapentin toxicity in children manifesting as behavioral changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900063-7

7 January 2021

10.1016/S0920-1211(99)00063-7

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018